Ads
related to: crispr therapeutics stock
Search results
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 6 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the ...
CRISPR Therapeutics’ (CRSP) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 4 days agoA number of other research analysts have also recently commented on CRSP. Needham & Company LLC reduced their price objective on CRISPR Therapeutics from ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 1 day agoShould you invest $1,000 in CRISPR Therapeutics right now? Before you buy stock in CRISPR ...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst
Guru Focus· 6 days agoRevenue: Reported at $504K, significantly below the estimated $26.55 million.Net Loss: Totaled $116.59 million, slightly above the estimated loss of $119.19 mi
Is Bluebird Bio Stock a Buy?
The Motley Fool via AOL· 9 hours agoCasgevy, another gene-editing treatment for SCD and TDT, earned approval recently. The team of Vertex Pharmaceuticals and CRISPR Therapeutics developed...
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 6 days agoIts important for readers to be cognizant of the risks that can affect the company's operations, and...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 2 days agostock price moves in the short term. Over the long term, the cheap valuation ratios mean that it's...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 4 days agoIt's in the process of launching its new gene editing therapy Casgevy, which it developed with ...
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024
InvestorPlace· 11 hours agoYou’d be sitting on 377% in gains if you invested in the overall market exactly 20 years back. The investing landscape right now may be better than many think, for those looking for buy-and-hold ...
